- The author revised the Stock Grader recommendations for 93 major blue-chip stocks based on institutional buying pressure and fundamental health data.
- Intel Corporation was upgraded to a strong rating, whereas CVS Health Corporation experienced a downgrade in its total evaluation.
- Investors are encouraged to review these updated stock rankings and utilize the proprietary screening tool for profit opportunities.